(0.24%) 5 144.00 points
(0.14%) 38 493 points
(0.42%) 17 920 points
(-0.64%) $83.31
(2.24%) $1.966
(-0.12%) $2 344.50
(-0.17%) $27.49
(2.78%) $947.70
(-0.04%) $0.934
(-0.08%) $11.02
(-0.27%) $0.798
(1.88%) $93.60
Live Chart Being Loaded With Signals
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular...
Stats | |
---|---|
Šios dienos apimtis | 8.77M |
Vidutinė apimtis | 6.57M |
Rinkos kapitalizacija | 107.55B |
EPS | $0 ( 2024-04-24 ) |
Kita pelno data | ( $0.580 ) 2024-07-25 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 61.49 |
ATR14 | $0.0320 (0.04%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Sorenson John Bradley | Buy | 16 351 | Common Stock |
2024-04-01 | Sorenson John Bradley | Sell | 16 351 | Common Stock |
2024-04-01 | Sorenson John Bradley | Sell | 16 351 | Stock Option (Right to Buy) |
2024-04-01 | Carruthers Wendy | Buy | 1 197 | Common Stock |
2024-04-01 | Carruthers Wendy | Buy | 3 066 | Common Stock |
INSIDER POWER |
---|
-44.36 |
Last 100 transactions |
Buy: 127 379 | Sell: 329 771 |
Tūris Koreliacija
Boston Scientific Corp Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
SQSP | 0.94 |
DTC | 0.934 |
CANE | 0.931 |
HCHC | 0.931 |
CRD-B | 0.93 |
SGG | 0.928 |
KOF | 0.928 |
OR | 0.927 |
IBA | 0.926 |
RELX | 0.924 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
CBU | -0.94 |
SFUN | -0.923 |
ASPN | -0.907 |
TUP | -0.907 |
SCHW | -0.902 |
NBHC | -0.902 |
JP | -0.897 |
NIC | -0.897 |
EVA | -0.889 |
ARIS | -0.887 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Boston Scientific Corp Koreliacija - Valiuta/Žaliavos
Boston Scientific Corp Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $14.24B |
Bruto pelnas: | $9.90B (69.49 %) |
EPS: | $1.080 |
FY | 2023 |
Pajamos: | $14.24B |
Bruto pelnas: | $9.90B (69.49 %) |
EPS: | $1.080 |
FY | 2022 |
Pajamos: | $12.68B |
Bruto pelnas: | $8.68B (68.44 %) |
EPS: | $0.450 |
FY | 2021 |
Pajamos: | $11.89B |
Bruto pelnas: | $8.13B (68.37 %) |
EPS: | $0.730 |
Financial Reports:
No articles found.
Boston Scientific Corp
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.